[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate]
- PMID: 15125434
[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate]
Similar articles
-
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.Eur J Clin Pharmacol. 1991;40(1):33-41. doi: 10.1007/BF00315136. Eur J Clin Pharmacol. 1991. PMID: 2060543
-
Fibrates and triglyceride metabolism.Eur J Clin Pharmacol. 1991;40 Suppl 1:S41-3. Eur J Clin Pharmacol. 1991. PMID: 2044642
-
Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.J Lipid Res. 1995 Dec;36(12):2541-51. J Lipid Res. 1995. PMID: 8847480
-
Fibrates and high-dose statins to prevent coronary heart disease events.Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8. Curr Cardiol Rep. 1999. PMID: 10980845 Review. No abstract available.
-
Hypertriglyceridemia and the fibrate trials.Curr Opin Lipidol. 2000 Dec;11(6):609-14. doi: 10.1097/00041433-200012000-00007. Curr Opin Lipidol. 2000. PMID: 11086334 Review.
Cited by
-
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.Adv Drug Deliv Rev. 2021 Sep;176:113888. doi: 10.1016/j.addr.2021.113888. Epub 2021 Jul 24. Adv Drug Deliv Rev. 2021. PMID: 34314787 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical